Skip to main content
Ralph Weichselbaum, MD, Radiation Oncology, Chicago, IL, University of Chicago Medical Center

RalphRWeichselbaumMD

Radiation Oncology • Chicago, IL

D.K. Ludwig Professor of Rad and Cellular Oncology, University of Chicago Medicine

Join to view full profile

Dr. Weichselbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weichselbaum's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1972 - 1975
  • Alameda Health System-Highland Hospital
    Alameda Health System-Highland HospitalInternship, Internal Medicine, 1971 - 1972
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - Present
  • IL State Medical License
    IL State Medical License 1984 - 2026
  • MA State Medical License
    MA State Medical License 1972 - 2009
  • American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 1997
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes  
    Ralph Weichselbaum, MD, Frontiers in Immunology
  • Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled Analysis  
    Julian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One

Press Mentions

  • Ludwig Chicago Nanotechnology Induces Therapeutic Immune Responses Against Multiple Types of Tumors
    Ludwig Chicago Nanotechnology Induces Therapeutic Immune Responses Against Multiple Types of TumorsOctober 29th, 2022
  • Ludwig Chicago Nanotechnology Induces Therapeutic Immune Responses Against Multiple Types of Tumors
    Ludwig Chicago Nanotechnology Induces Therapeutic Immune Responses Against Multiple Types of TumorsOctober 28th, 2022
  • Nanoparticles Upgraded to Deliver Killer Sting on Recalcitrant Tumors
    Nanoparticles Upgraded to Deliver Killer Sting on Recalcitrant TumorsOctober 28th, 2022
  • Join now to see all

Grant Support

  • P-3: Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2011–2012
  • Radiation Enhancement Of HSV Anti-Tumor EffectsNational Cancer Institute2009–2011
  • P-3: Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2010
  • Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2009
  • Mechanisms Of Resistance To Radio Inducible Gene TherapyNational Cancer Institute2005–2009
  • DNA Damage Targeted Gene Therapy In Head &Neck CancerNational Cancer Institute2005–2009
  • Gene Therapy For Extension Of Vein Graft PatencyNational Heart, Lung, And Blood Institute2003–2005
  • Design Of Genetically Engineered HSV For Cancer TherapyNational Cancer Institute1997–2001
  • Training Program In Environmental Biology (NRSA)National Cancer Institute1993–2000
  • Pilot--Gene Therapy In Oral CancersNational Institute Of Dental &Craniofacial Research1996–1999
  • Novel Methods Of Tumor Cell RadiosensitizationNational Cancer Institute1995–1998
  • 3D Dose Escalation For Prostate CancerNational Cancer Institute1994–1996
  • Radiation Gene Induction--Applications To Gene TargetingNational Cancer Institute1993–1995
  • Assays Of Tumor Response To RadiotherapyNational Cancer Institute1986–1994
  • 3-Dose Escalation Study For Prostate CancerNational Cancer Institute1993
  • X-RAY &Molecular Probes Of RetinoblastomaNational Cancer Institute1988–1992
  • Environmental BiologyNational Cancer Institute1988–1992
  • X-RAY And Molecular Probes Of RetinoblastomaNational Cancer Institute1988–1990
  • Training Program In Environmental BiologyNational Cancer Institute1986–1987

Professional Memberships

Hospital Affiliations

Dr. Ralph Weichselbaum, Dr. Ralph Weichselbaum, MD, Dr. R Weichselbaum, Dr. Ralph R Weichselbaum